Revvity (RVTY) Liabilities from Discontinued Operations (2010 - 2023)
Revvity's (RVTY) quarterly Liabilities from Discontinued Operations came in at 272865000.0 in Q1 2023, up 32.72% YoY from 205594000.0 in Q1 2022, and up 32.72% on a QoQ basis from 205594000.0 in Q1 2022.
Revvity (RVTY) Liabilities from Discontinued Operations (2010 - 2023) Analysis & Trends
Revvity (RVTY) has 14 years of Liabilities from Discontinued Operations data on file, last reported at 272865000.0 in Q1 2023.
- Quarterly Liabilities from Discontinued Operations rose 32.72% year-over-year to 272865000.0 in Q1 2023, while the trailing twelve-month figure through Jan 2023 was 272865000.0 (up 32.72% YoY) and the FY2023 annual result came in at 272865000.0, up 32.72% from the prior year.
- Liabilities from Discontinued Operations improved to 272865000.0 in Q1 2023, from 205594000.0 in the prior quarter.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of 272865000.0 in Q1 2023 to a low of 2097000.0 in Q3 2020.
- A 5-year average of 49542600.0 and a median of 2121000.0 in 2019 frame the typical range for Liabilities from Discontinued Operations.
- Annual changes were most pronounced in 2019 — Liabilities from Discontinued Operations decreased 2.45% — and 2022, when it jumped 9361.3%.
- Tracing RVTY's Liabilities from Discontinued Operations over 5 years: stood at 2112000.0 in 2019, then decreased by 0.71% to 2097000.0 in 2020, then grew by 3.62% to 2173000.0 in 2021, then jumped by 9361.3% to 205594000.0 in 2022, then surged by 32.72% to 272865000.0 in 2023.
- The last three Liabilities from Discontinued Operations figures came in at 272865000.0 (Q1 2023), 205594000.0 (Q1 2022), and 2173000.0 (Q1 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn |
| 10 | Revvity | 12.76 Bn | 11.90 Bn | 387.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 1, 2023 | 272.87 Mn |
| Jan 1, 2023 | 272.87 Mn |
| Jan 2, 2022 | 205.59 Mn |
| Jan 2, 2022 | 205.59 Mn |
| Jan 3, 2021 | 2.17 Mn |
| Jan 3, 2021 | 2.17 Mn |
| Oct 4, 2020 | 2.10 Mn |
| Oct 4, 2020 | 2.10 Mn |
| Jul 5, 2020 | 2.10 Mn |
| Jul 5, 2020 | 2.10 Mn |
| Apr 5, 2020 | 2.11 Mn |
| Apr 5, 2020 | 2.11 Mn |
| Dec 29, 2019 | 2.11 Mn |
| Dec 29, 2019 | 2.11 Mn |
| Sep 29, 2019 | 2.11 Mn |
| Sep 29, 2019 | 2.11 Mn |
| Jun 30, 2019 | 2.13 Mn |
| Jun 30, 2019 | 2.13 Mn |
| Mar 31, 2019 | 2.13 Mn |
| Mar 31, 2019 | 2.13 Mn |